Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: Additional information regarding baseline lesion composition's impact on vision outcomes - TAP report no. 3

Archives of Ophthalmology

Volumn 120, Issue 11, 2002, Pages 1443-1454

  Bressler, Neil M ^a,b   Arnold, Jennifer ^c   Benchaboune, Mustapha ^c   Blumenkranz, Mark S ^c   Fish, Gary E ^c   Gragoudas, Evangelos S ^c   Lewis, Hilel ^c   Schmidt Erfurth, Ursula ^c   Slakter, Jason S ^c   Bressler, Susan B ^c   Manos, Kelly ^c   Hao, Yong ^c   Haynes, Laurie ^c   Koester, John ^c   Reaves, Al ^c   Strong, H Andrew ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Novartis Ophthalmics Inc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRACE ELEMENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RISK; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VISUAL ACUITY;

EID: 0036875646     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.11.1443     Document Type: Article

References (6)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol. 1999;117:1329-1345.
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2, Arch Ophthalmol. 2001; 119:198-207.
3. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991;109:1242-1257.
4. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol. 2001;131:541-560.
5. Rosenfeld PJ, and the TAP Study Group. Visual outcomes in patients with minimally classic choroidal neovascularization (CNV): rationale for the Visudyne in Minimally Classic CNV (VIM) Trial [abstract]. Invest Ophthalmol Vis Sci. 2001; 42:S512.
6. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994;112:480-488.